| Financial Year |
March 31 2023 |
| Monetary Funds |
659,765,748.80 |
| Held-for-trading Financial Assets |
41,523,520.12 |
| Notes Receivable |
820,329,320.46 |
| Accounts Receivable |
962,609,223.29 |
| Advances to Suppliers |
24,359,830.97 |
| Other Receivables |
29,325,233.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
314,289,804.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,158,735.08 |
| Total Current Assets |
2,868,401,416.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
123,614,091.91 |
| Investment Properties |
-- |
| Fixed Assetes |
255,015,036.64 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
308,807,224.74 |
| R&D expenses |
81,027,902.94 |
| Goodwill |
413,403,376.29 |
| Long-Term Deferred and Prepaid Expenses |
18,595,553.84 |
| Deferred Income Tax Assets |
94,355,153.28 |
| Other Non-Current Assets |
1,698,131.08 |
| Sub-Total of Non-Current Assets |
1,673,676,489.47 |
| Total Assets |
4,542,077,906.05 |
| Short-Term Loans |
34,167,817.61 |
| Trading Financial liabilities |
-- |
| Notes Payable |
22,898,602.87 |
| Accounts Payable |
429,687,528.72 |
| Accounts Received In Advance |
1,417,272.99 |
| Employee Compensation Payable |
118,251,405.32 |
| Taxes Payable |
28,586,901.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
55,060,526.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
39,842,727.75 |
| Other Current Liabilities |
17,196,769.05 |
| Sub-Total of Current Liabilities |
916,626,074.29 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
47,571,390.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
138,964,718.88 |
| Total Liabilities |
1,055,590,793.17 |
| Paid-In Capital(Or Share Stock) |
798,584,413.00 |
| Capital Surplus |
1,310,944,795.29 |
| Surplus Reserve |
181,451,960.21 |
| LESS:Treasury Stock |
122,460,467.41 |
| Undistributed Profits |
1,357,945,894.81 |
| Minority Stockholder's Interest |
-351,637.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,486,838,750.51 |
| Owner's Equity（Stockholder's Equity） |
3,486,487,112.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,542,077,906.05 |
